{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:21:45Z","timestamp":1773184905670,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Recurrent\n                      <jats:italic toggle=\"yes\">Acinetobacter<\/jats:italic>\n                      infections (AIs) pose significant treatment challenges and contribute to an increased healthcare burden. Limited data exist on recurrent infections in pediatric patients, making it essential to better define their clinical and microbiological characteristics to guide effective management strategies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrospectively reviewed patients 0\u201318 years of age hospitalized between 2019 and 2024 with confirmed AI. Recurrent infection was defined as a new episode occurring within 90 days after clinical recovery and documented negative cultures. Clinical, microbiological and laboratory data, as well as treatment regimens and outcomes, were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 150 pediatric patients with AI, the majority had underlying diseases (82.7%) and prolonged hospital stays exceeding 30 days (71.4%). Overall, 66.7% of isolates were multidrug- or extensively drug-resistant. Recurrent AI developed in 15.3% of patients, most frequently associated with port-catheter and bloodstream infections, and was significantly linked to longer hospitalization. Overall mortality was 34.7%, increasing to 47.8% in patients with recurrent AI. Independent risk factors for mortality included intensive care unit admission, the presence of multiple clinical findings, lymphopenia and hypocalcemia, while recurrent AI was independently associated with prolonged hospital stay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Recurrent AIs in pediatric patients impose a substantial clinical burden, being associated with both prolonged hospitalization and increased mortality. Identifying high-risk groups, particularly those with underlying diseases and critical illness, and ensuring closer monitoring with targeted management strategies are essential to improve clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005051","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:00:52Z","timestamp":1772636452000},"page":"324-329","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Beyond the First Infection: Exploring Recurrence in Pediatric Acinetobacter Cases"],"prefix":"10.1097","volume":"45","author":[{"given":"Metehan Ya\u015far","family":"Tekin","sequence":"first","affiliation":[{"name":"Department of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2538-2872","authenticated-orcid":false,"given":"Saliha","family":"Kanik-Y\u00fcksek","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Disease, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University Medical Faculty, Ankara, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belgin","family":"G\u00fclhan","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tu\u011fba","family":"Erat","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatice K\u00fcbra","family":"Konca","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seval","family":"\u00d6zen","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysun","family":"Yah\u015fi","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcls\u00fcm \u0130clal","family":"Bayhan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Disease, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University Medical Faculty, Ankara, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asli Nur","family":"\u00d6zkaya-Parlakay","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Disease, Ankara Bilkent City Hospital, Ankara Yildirim Beyazit University Medical Faculty, Ankara, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bedia","family":"Din\u00e7","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Ankara Bilkent City Hospital, University of Health Sciences, Ankara, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"R1-20260310","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2010\/690715","article-title":"Systematic review of invasive Acinetobacter infections in children.","volume":"21","author":"Hu","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"R2-20260310","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1128\/JCM.01194-12","article-title":"Recurrent bacteremia caused by the Acinetobacter calcoaceticus\u2014A. baumannii complex: relapse or reinfection?","volume":"50","author":"Lai","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R3-20260310","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fcimb.2020.00253","article-title":"Insights into mechanisms of biofilm formation in Acinetobacter baumannii and implications for uropathogenesis.","volume":"10","author":"Colquhoun","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"R4-20260310","doi-asserted-by":"crossref","first-page":"38","DOI":"10.5152\/TurkArchPediatr.2024.23153","article-title":"Clinical reflections of Acinetobacter infections in children in a quaternary-care hospital: a five-year single-center experience.","volume":"59","author":"Elvan-T\u00fcz","year":"2024","journal-title":"Turk Arch Pediatr"},{"key":"R5-20260310","doi-asserted-by":"crossref","first-page":"ofz263","DOI":"10.1093\/ofid\/ofz263","article-title":"Whole-genome sequencing to differentiate relapse from reinfection in community-onset bacteremic Acinetobacter baumannii pneumonia.","volume":"6","author":"Meumann","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"R6-20260310","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ajic.2013.06.017","article-title":"Case-control analysis of endemic Acinetobacter baumannii bacteremia in the neonatal intensive care unit.","volume":"42","author":"Hsu","year":"2014","journal-title":"Am J Infect Control"},{"key":"R7-20260310","first-page":"18","article-title":"Risk factors and prognosis of carbapenem-resistant Acinetobacter baumannii infection in children: a retrospective case-control study in a pediatric intensive care unit.","volume":"142","author":"Song","year":"2024","journal-title":"J Hosp Infect"},{"key":"R8-20260310","first-page":"1210","article-title":"Infection prevention measures during an outbreak of multidrug-resistant Acinetobacter baumannii in a pediatric intensive care unit.","volume":"21","author":"Gurgen","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R9-20260310","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R11-20260310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diagmicrobio.2009.04.011","article-title":"Characterization of Acinetobacter baumannii genotypes recovered from patients with repeated colonization or infection.","volume":"65","author":"Qi","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R12-20260310","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhin.2023.11.002","article-title":"Impact of antibiotic exposure on antibiotic-resistant Acinetobacter baumannii isolation in intensive care unit patients: a systematic review and meta-analysis.","volume":"143","author":"De Blasiis","year":"2024","journal-title":"J Hosp Infect"},{"key":"R13-20260310","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JRS-220037","article-title":"A systematic review and meta-analysis for risk factor profiles in patients with resistant Acinetobacter baumannii infection relative to control patients.","volume":"34","author":"Deshwal","year":"2023","journal-title":"Int J Risk Saf Med"},{"key":"R14-20260310","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12879-025-10781-1","article-title":"Mortality and clinical outcomes of colistin versus colistin-based combination therapy for infections caused by multidrug-resistant Acinetobacter baumannii in critically ill patients.","volume":"25","author":"Alwazzeh","year":"2025","journal-title":"BMC Infect Dis"},{"key":"R15-20260310","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/CCM.0000000000000933","article-title":"Excess mortality associated with colistin-tigecycline compared with colistin-carbapenem combination therapy for extensively drug-resistant Acinetobacter baumannii Bacteremia: a multicenter prospective observational study.","volume":"43","author":"Cheng","year":"2015","journal-title":"Crit Care Med"},{"key":"R16-20260310","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1186\/s12879-024-09899-5","article-title":"Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial sequential analysis.","volume":"24","author":"Zhan","year":"2024","journal-title":"BMC Infect Dis"},{"key":"R17-20260310","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/CCM.0000000000001029","article-title":"Combination therapy for extreme drug-resistant Acinetobacter baumannii: ready for prime time?","volume":"43","author":"Spellberg","year":"2015","journal-title":"Crit Care Med"},{"key":"R18-20260310","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/14787210.2025.2532024","article-title":"Risk factors for colistin-resistant, extensively drug-resistant (XDR) and pandrug-resistant (PDR) Acinetobacter baumannii infections: a review.","volume":"23","author":"Vrysis","year":"2025","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R19-20260310","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jhin.2024.04.013","article-title":"Risk factors for multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infection of patients admitted in intensive care unit: a systematic review and meta-analysis.","volume":"149","author":"Diao","year":"2024","journal-title":"J Hosp Infect"},{"key":"R20-20260310","doi-asserted-by":"crossref","first-page":"dlaf134","DOI":"10.1093\/jacamr\/dlaf134","article-title":"The global epidemiology of carbapenem-resistant Acinetobacter baumannii.","volume":"7","author":"Boutzoukas","year":"2025","journal-title":"JAC Antimicrob Resist"},{"key":"R21-20260310","doi-asserted-by":"crossref","first-page":"107605","DOI":"10.1016\/j.micpath.2025.107605","article-title":"Acinetobacter baumannii: a comprehensive review of global epidemiology, clinical implications, host interactions, mechanisms of antimicrobial resistance and mitigation strategies.","volume":"204","author":"Sharma","year":"2025","journal-title":"Microb Pathog"},{"key":"R22-20260310","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/antibiotics11081076","article-title":"Control of healthcare-associated carbapenem-resistant Acinetobacter baumannii by enhancement of infection control measures.","volume":"11","author":"Wong","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"R23-20260310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12427","article-title":"ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients.","volume":"20","author":"Tacconelli","year":"2014","journal-title":"Clin Microbiol Infect"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T04:00:48Z","timestamp":1773115248000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005051","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]}}}